Ralph Boccia, MD

Articles by Ralph Boccia, MD

Dr. Boccia on Managing Adverse Events With CAR T-Cell Therapy

November 17th 2018

Ralph Boccia, MD, an oncologist at the Center for Cancer and Blood Disorders, associate clinical professor at Georgetown University, discusses managing adverse events associated with chimeric antigen receptor T-cell therapy.

Latest Updated Articles

Dr. Boccia on Managing Adverse Events With CAR T-Cell Therapy
Published: November 17th 2018 | Updated:

Ralph Boccia, MD

Articles by Ralph Boccia, MD

Dr. Boccia on Managing Adverse Events With CAR T-Cell Therapy

Latest Updated Articles

Trending on CGTlive®

Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

CGTLive®’s Weekly Rewind – October 17, 2025

Guess the Therapy Answer October 16, 2025